This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with Chronic rhinosinusitis with nasal polyps (CRSwNP).
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, ÍøºìºÚÁÏ-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal…
39 publications
2018
American Journal of Otolaryngology
2018
The Laryngoscope
•2018
2018
2018